Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Company's Board...

PR Newswire;  February 12, 2008 ;     573 words ......of Directors of the company. Dr. Huh will step down as Nektar's Chief Operating Officer...the transformation of Nektar into a drug development company. About Nektar Nektar Therapeutics is a biopharmaceutical company that develops and enables...

Nektar Therapeutics Issues Statement on Exubera.

PR Newswire;  October 18, 2007 ;     693 words ......advancement for diabetic patients. Nektar's business has multiple sources...proprietary therapies. The company continues to develop NKTR-1...Bayer Schering Pharma AG. Nektar also has a number of other...programs in development. About Nektar Nektar Therapeutics is a biopharmaceutical ...

Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer.

PR Newswire;  August 23, 2007 ;     652 words ......Harkness reports to Nektar President and CEO...integral member of the company's new management...management team at Nektar, Harkness said...biopharmaceutical company with our proven...pipelines. About Nektar Nektar Therapeutics is a biopharmaceutical company with a mission ...

Nektar Therapeutics Appoints Lutz Lingnau as New Board Member.

PR Newswire;  August 29, 2007 ;     695 words ......important point in the company's evolution, said...President and CEO of Nektar. As we continue...team as they move Nektar's clinical pipeline...and advance the company's strategic business...December 2006. About Nektar Nektar Therapeutics is a biopharmaceutical company with a ...

Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar...

PR Newswire;  October 21, 2008 ;     700+ words ......passcode of 50627256. About Nektar Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics...chemistry technology platforms. Nektar's technology and drug development...Novartis and reflect the company's current views as to its...

Nektar Therapeutics Repurchases $100 Million of Convertible Debt and...

PR Newswire;  November 6, 2008 ;     700+ words ......relations section of the company's website at http://www.nektar.com/. About Nektar...a biopharmaceutical company developing novel therapeutics...please visit http://www.nektar.com/. This press release...statements that reflect the company's current views regarding...

Nektar Promotes John Nicholson to Serve as Chief Financial Officer.

PR Newswire;  December 11, 2007 ;     566 words ......CFO) of the company. Nicholson reports to Nektar's President...to transition Nektar from a drug delivery entity to a company that develops...service to the company, Robin said. Nektar Therapeutics...biopharmaceutical company with a mission...

Nektar Therapeutics Creates New PEGylation and Pulmonary Research Units to...

PR Newswire;  September 18, 2007 ;     700+ words ......to drive the company's research initiatives under Nektar's PEGylation...that leverage Nektar's proprietary...including the company's inhaled antibiotic...Kansas. About Nektar Nektar Therapeutics...biopharmaceutical company with a mission...

Nektar Therapeutics Announces Second Quarter 2008 Results.

PR Newswire;  August 6, 2008 ;     700+ words ......PRNewswire-FirstCall/ -- Nektar Therapeutics today announced the company's financial results...67859021 About Nektar Nektar Therapeutics is a biopharmaceutical company that develops and...visit http://www.nektar.com/. This press...that reflect the company's current views...

Nektar Announces Restructuring to Complete Its Transition to a...

M2 Presswire;  February 13, 2008 ;     700+ words ......are transforming Nektar into a world-class drug development company and these changes...Executive Officer of Nektar. This restructuring...direction of our company and strengthens our...insulin programs. Nektar has made significant...proprietary pipeline. The company recently ...

Nektar Commences Phase 2 Clinical Development Program for NKTR-102...

PR Newswire;  January 8, 2008 ;     700+ words ......colorectal cancer. NKTR-102 is Nektar's lead oncolytic candidate using the company's innovative small molecule...is a major achievement for Nektar, said Howard W. Robin, Nektar...standard irinotecan. About Nektar Nektar Therapeutics is a biopharmaceutical company that develops ...

Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice...

PR Newswire;  August 6, 2008 ;     700+ words ......and Regulatory Affairs at Nektar. He is responsible for overseeing...of drug development at the company and will drive clinical and...organization that will advance Nektar's programs rapidly through the clinic. About Nektar Nektar Therapeutics is a biopharmaceutical company that ...

Nektar Therapeutics to Webcast R&D Day on November 12th.

PR Newswire;  October 27, 2008 ;     250 words ......at approximately 3:30 p.m. Nektar's R&D Day will consist of...presentations and Q&A related to the Company's clinical development programs...Nektar homepage, http://www.nektar.com/. The webcast will be...November 26, 2008. About Nektar Nektar Therapeutics is a biopharmaceutical ...

Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by...

PR Newswire;  May 12, 2008 ;     700+ words ......indications, as well as manufacturing revenues. With the use of Nektar's advanced PEGylation technology, the properties of therapeutic...decreasing immunogenicity, and reducing dosing frequency. Nektar proprietary technology uses advanced conjugation chemistry...patients. Hematide(TM) is a trademark of Affymax. ...

Nektar Announces Agreement With Baxter to Develop New PEGylated...

PR Newswire;  December 20, 2007 ;     700+ words ......and Europe today. About Nektar Nektar Therapeutics is a biopharmaceutical company with a mission to develop...PEGylation technology platforms. Nektar pulmonary and PEGylation...of the agreement between Nektar and Baxter is set forth in...Report on Form 8-K filed by Nektar with the ...